AIM Research · specialised in data and AIIndependent · Analyst-led · Vendor-neutral

    Vendor passport · Updated Nov 2026

    Agilisium

    Data Engineering Service ProvidersGenerative AI Service ProvidersAI Service Providers for Life Sciences and HealthcareMLOps Service Providers

    Placed in 5 PeMa markets and a Leader in 2 of them, with its strongest showing in Generative AI Service Providers and AI Service Providers for Life Sciences and Healthcare.

    5

    PeMa markets

    2

    Leader placements

    5

    AIM reports

    2014

    Founded

    Los Angeles, United States

    Headquarters

    Placement history

    How its position has moved since 2018

    One row per market, one dot per PeMa study. Lines join consecutive years.

    201820192020202120222023202420252026
    AI Service Providers for Life Sciences and HealthcareLeader · 2026
    Generative AI Service ProvidersGrowth · 2023Growth · 2024Leader · 2026
    Data Engineering Service ProvidersSeasoned · 2023Growth · 2025
    Data Science Service ProvidersSeasoned · 2024Seasoned · 2025
    MLOps Service ProvidersGrowth · 2024Seasoned · 2025
    LeaderSeasonedGrowthNot evaluated

    Profile

    About Agilisium

    Agilisium is a life sciences focused data and AI services firm founded in 2014 and headquartered in Los Angeles, with large delivery operations in India.

    It reports more than 1,050 employees, six global delivery centres and over 25 life sciences customers. The company works across the pharma and biotech value chain, from clinical study setup to commercial analytics, and is an AWS partner with both life sciences and generative AI competencies. In 2026 it launched a forward deployment model that places domain-trained experts and client-specific agents inside customer teams, became a Select Services Partner in Anthropic's Claude Partner Network and was recognised by Frost & Sullivan for agentic AI in life sciences. AIM Research places Agilisium as a Leader in AI Service Providers for Life Sciences and Healthcare and in Generative AI Service Providers, in the Growth group for Data Engineering, and as Seasoned in Data Science and MLOps.

    Steady

    Website agilisium.com

    Buyer signals

    What changed lately

    Agilisium receives Frost & Sullivan 2026 recognition for agentic AI in life sciences

    Frost & Sullivan gave Agilisium its 2026 Global Technology Innovation Leadership Recognition for agentic AI in life sciences, citing its domain-oriented agent framework with built-in governance. The company reported more than 1,050 staff, six delivery centres, over 25 life sciences customers and more than 190 live projects, and said its forward deployment model can bring an agent into production in about 60 days.

    Buyer takeawayPharma and biotech buyers get third-party support for Agilisium's production track record in regulated workflows, though the outcome figures it cites are self-reported.

    Shortlisting a generative ai partner? Get an analyst-reviewed shortlist built from PeMa evidence.

    Build my shortlist →

    Reports featuring Agilisium

    5 AIM Research reports

    All reports →

    Analyst scorecard

    Scores, strengths and buyer signals

    Market names and placements are public. Scores and buyer signals are for signed-in buyers.

    MarketPlacementPenetrationMaturityBuyer signal
    Data Engineering Service ProvidersGrowth
    Generative AI Service ProvidersLeaders
    AI Service Providers for Life Sciences and HealthcareLeaders
    MLOps Service ProvidersSeasoned
    Data Science Service ProvidersSeasoned

    Buyers only

    Sign in to see the full scorecard

    Free for enterprise buyers with a work email.

    Sign in →

    Frequently asked

    Questions about Agilisium

    Agilisium is a life sciences focused data and AI services firm founded in 2014 and headquartered in Los Angeles, with large delivery operations in India. It reports more than 1,050 employees, six global delivery centres and over 25 life sciences customers.